首页> 外国专利> It treats and for introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treating tumour

It treats and for introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treating tumour

机译:它治疗并引入未成熟的树突状细胞和/或细胞毒性T淋巴细胞以及抗TNF抗体来治疗肿瘤

摘要

Apply the present invention relates to treatment and method to patient and treats. The present invention includes to introduce immature dendritic cell to enter patient's D2E7 and be introduced into patient's body. Dendritic Cells introduces introducing in tumor and/or by container, in D2E7 tumour and/or by container and/or subcutaneous. Immature dendritic cells can be formed as cultivating cell in the medium by collecting cell from patient and monocyte. The present invention can effectively degenerate, and reduce or eliminate tumour cell in the tumor tissues of patient, including metastatic tumor. In addition, processing of the invention can be in no conventional therapy, such as radiation and chemotherapy.
机译:本发明涉及对患者和治疗的治疗和方法。本发明包括引入未成熟的树突状细胞进入患者的D2E7并引入患者体内。树突状细胞在肿瘤中和/或通过容器,在D2E7肿瘤中和/或通过容器和/或皮下引入引入。通过从患者和单核细胞收集细胞,可以在培养基中形成未成熟树突细胞作为培养细胞。本发明可以有效地变性,减少或消除患者包括转移性肿瘤在内的肿瘤组织中的肿瘤细胞。另外,本发明的处理不能采用常规疗法,例如放射疗法和化学疗法。

著录项

  • 公开/公告号US10278992B2

    专利类型

  • 公开/公告日2019-05-07

    原文格式PDF

  • 申请/专利权人 KENICHIRO HASUMI;

    申请/专利号US201815889584

  • 发明设计人 KENICHIRO HASUMI;

    申请日2018-02-06

  • 分类号A01N63/00;A61K45/00;A61K47/00;A61K35/15;A61K39/395;C12N5/0784;C12N5/0783;A61K35/17;C07K16/24;A61K38/19;A61K39/00;

  • 国家 US

  • 入库时间 2022-08-21 12:12:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号